Search Results - "Walther Boer, Mark"

Long-Term Type 1 Diabetes Enhances In-Stent Restenosis after Aortic Stenting in Diabetes-Prone BB Rats by Onuta, Geanina, Groenewegen, Hendrik C., Klatter, Flip A., Walther Boer, Mark, Goris, Maaike, van Goor, Harry, Roks, Anton J. M., Rozing, Jan, de Smet, Bart J. G. L., Hillebrands, Jan-Luuk

“…Type 1 diabetic patients have increased risk of developing in-stent restenosis following endovascular stenting. Underlying pathogenetic mechanisms are not…”
Get full text

Functional genomics of the evolution of increased resistance to parasitism in Drosophila by WERTHEIM, BREGJE, KRAAIJEVELD, ALEX R., HOPKINS, MEIRION G., WALTHER BOER, MARK, GODFRAY, H. CHARLES J.

“…Individual hosts normally respond to parasite attack by launching an acute immune response (a phenotypic plastic response), while host populations can respond…”
Get full text

Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats by ONUTA, Geanina, RIENSTRA, Heleen, FREARK DE BOER, Jan, WALTHER BOER, Mark, ROKS, Anton J. M, KLATTER, Flip A, UGES, Donald R. A, NAVIS, Gerjan, ROZING, Jan, HILLEBRANDS, Jan-Luuk

“…Transplant arteriosclerosis is a leading cause of chronic transplant dysfunction and is characterized by occlusive neointima formation in intragraft arteries…”
Get full text

Dichotomous Effects of Rosiglitazone in Transplantation-Induced Systemic Vasodilator Dysfunction in Rats by ONUTA, Geanina, HILLEBRANDS, Jan-Luuk, RIENSTRA, Heleen, WALTHER BOER, Mark, KLATTER, Flip A, NAVIS, Gerjan, RAZING, Jan, ROKS, Anton J. M

“…Transplantation-induced systemic endothelial dysfunction causes severe cardiovascular morbidity and mortality after transplantation. Interventions that improve…”
Get full text

Spironolactone ameliorates transplant vasculopathy in renal chronic transplant dysfunction in rats by Waanders, Femke, Rienstra, Heleen, Boer, Mark Walther, Zandvoort, André, Rozing, Jan, Navis, Gerjan, van Goor, Harry, Hillebrands, Jan-Luuk

“…Chronic transplant dysfunction (CTD) is the leading cause of long-term renal allograft loss and is characterized by specific histological lesions including…”
Get more information

Development of transplant vasculopathy in aortic allografts correlates with neointimal smooth muscle cell proliferative capacity and fibrocyte frequency by Onuta, Geanina, van Ark, Joris, Rienstra, Heleen, Boer, Mark Walther, Klatter, Flip A, Bruggeman, Cathrien A, Zeebregts, Clark J, Rozing, Jan, Hillebrands, Jan-Luuk

“…Abstract Objective Transplant vasculopathy consists of neointima formation in graft vasculature resulting from vascular smooth muscle cell recruitment and…”
Get full text

Long-Term Type 1 Diabetes Enhances In-Stent Restenosis after Aortic Stenting in Diabetes-Prone BB Rats by Onuta, Geanina, Groenewegen, Hendrik C., Klatter, Flip A., Walther Boer, Mark, Goris, Maaike, van Goor, Harry, Roks, Anton J. M., Rozing, Jan, de Smet, Bart J. G. L., Hillebrands, Jan-Luuk

“…Type 1 diabetic patients have increased risk of developing in-stent restenosis following endovascular stenting. Underlying pathogenetic mechanisms are not…”
Get full text